GABAergic drugs and Alzheimer's disease (Q39768852)

14 September 2017

title

GABAergic drugs and Alzheimer's disease (English)

1 reference

14 September 2017

0 references

Agenor Limon

1

1 reference

14 September 2017

Jorge Mauricio Reyes-Ruiz

series ordinal

2

1 reference

14 September 2017

Ricardo Miledi

series ordinal

3

1 reference

14 September 2017

publication date

1 February 2011

1 reference

Future Medicinal Chemistry

14 September 2017

published in

1 reference

14 September 2017

volume

3

1 reference

14 September 2017

issue

2

1 reference

14 September 2017

page(s)

149-153

1 reference

Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization

14 September 2017

cites work

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Alzheimer's failure raises questions about disease-modifying strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Intracellular amyloid-beta in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Aberrant excitatory neuronal activity and compensatory remodeling of inhibitory hippocampal circuits in mouse models of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Beta-amyloid causes depletion of synaptic vesicles leading to neurotransmission failure

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Effectiveness of Cholinesterase Inhibitors and Memantine for Treating Dementia: Evidence Review for a Clinical Practice Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

GABA(A) receptors in aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Cholinergic control of GABA release: emerging parallels between neocortex and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Defined types of cortical interneurone structure space and spike timing in the hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

GABAergic control of neurite outgrowth and remodeling during development and adult neurogenesis: general rules and differences in diverse systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

GABAergic deafferentation hypothesis of brain aging and Alzheimer's disease revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

An inverse agonist selective for alpha5 subunit-containing GABAA receptors enhances cognition.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

The physiological properties and therapeutic potential of alpha5-GABAA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Preclinical and clinical pharmacology of the GABAA receptor alpha5 subtype-selective inverse agonist alpha5IA.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Variations on an inhibitory theme: phasic and tonic activation of GABA(A) receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Which GABA(A) receptor subunits are necessary for tonic inhibition in the hippocampus?

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Channel-mediated tonic GABA release from glia.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

GABAergic interneuron dysfunction impairs hippocampal neurogenesis in adult apolipoprotein E4 knockin mice

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Of mice and not men: differences between mouse and human immunology

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Important differences between human and mouse APOE gene promoters: limitation of mouse APOE model in studying Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

An immunohistochemical study of GABA A receptor gamma subunits in Alzheimer's disease hippocampus: relationship to neurofibrillary tangle progression

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Kaitocephalin antagonism of glutamate receptors expressed in Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

In situ Abeta pores in AD brain are cylindrical assembly of Abeta protofilaments.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

The beta-amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Membrane biophysics and mechanics in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Microtransplantation of functional receptors and channels from the Alzheimer's brain to frog oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Properties of glutamate receptors of Alzheimer's disease brain transplanted to frog oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

BDNF modulates GABAA receptors microtransplanted from the human epileptic brain to Xenopus oocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Microtransplantation of neurotransmitter receptors from postmortem autistic brains to Xenopus oocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

A Rosetta stone for analysis of human membrane protein function

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

Microtransplantation of ligand-gated receptor-channels from fresh or frozen nervous tissue into Xenopus oocytes: a potent tool for expanding functional information.

21 January 2018

1 reference

https://api.crossref.org/works/10.4155%2FFMC.10.291

21 January 2018

Identifiers

DOI

10.4155/FMC.10.291

1 reference

14 September 2017

1 reference